• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Aehr Test Systems Shares Are Trading Lower By 15%; Here Are 20 Stocks Moving Premarket

    1/10/24 8:02:59 AM ET
    $AEHR
    $AWIN
    $ELEV
    $GGE
    Electrical Products
    Industrials
    Aerospace
    Industrials
    Get the next $AEHR alert in real time by email

    Shares of Aehr Test Systems (NASDAQ:AEHR) shares fell sharply in pre-market trading after the company lowered its full-year revenue guidance.

    The company said revenue will likely be impacted by an anticipated delay in the timing of new orders from current and new customers.

    Aehr Test Systems shares dipped 15% to $18.99 in pre-market trading.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Exicure, Inc. (NASDAQ:XCUR) shares rose 35.5% to $0.84 in pre-market trading. Exicure was granted broad U.S. patent #11866700 for "Liposomal Nucleic Acid Constructs Presenting Antisense Oligonucleotides For Knockdown Of Interleukin 17 Mrna (For Inflammation From Cancer, Obesity, Diabetes, Alzheimer's)."
    • iCoreConnect Inc. (NASDAQ:ICCT) shares rose 32.3% to $1.72 in pre-market trading. iCoreConnect announced strategic acquisition of Verifi Dental.
    • Zoomcar Holdings, Inc. (NASDAQ:ZCAR) shares jumped 15.8% to $7.40 in pre-market trading after surging more than 60% on Tuesday.
    • Microvast Holdings, Inc. (NASDAQ:MVST) shares gained 13.8% to $1.40 in pre-market trading after falling 5% on Tuesday.
    • SMART Global Holdings Inc. (NASDAQ:SGH) gained 10.7% to $20.45 in pre-market trading after the company posted better-than-expected earnings for its first quarter and announced approval of $75 million share repurchase authorization.
    • PriceSmart, Inc. (NASDAQ:PSMT) gained 10% to $80.20 in pre-market trading as the company reported better-than-expected earnings for its first quarter on Tuesday.
    • TG Therapeutics, Inc. (NASDAQ:TGTX) surged 9.1% to $22.93 in pre-market trading. TG Therapeutics recently announced that it has entered into an agreement with Precision BioSciences to acquire a worldwide license to Precision's Azercabtagene Zapreleucel (azer-cel), an allogeneic CD19 CAR T cell therapy program for autoimmune diseases and all other non-oncology indications.
    • Hanryu Holdings, Inc. (NASDAQ:HRYU) shares climbed 8.5% to $0.91 in pre-market trading after falling around 7% on Tuesday.
    • Green Giant Inc. (NASDAQ:GGE) shares rose 7.6% to $0.0440 in pre-market trading after declining around 5% on Tuesday.
    • Intuitive Surgical, Inc. (NASDAQ:ISRG) gained 5.3% to $348.01 in pre-market trading. Intuitive Surgical said it sees preliminary revenue of $1.93 billion for the fourth quarter, versus market estimates of $1.87 billion.

    Losers

    • Roma Green Finance Limited (NASDAQ:ROMA) shares fell 29.3% to $2.05 in pre-market trading after dipping over 27% on Tuesday. Roma Green Finance announced pricing of $12.3 million public offering of 2,449,943 of shares at price of $4.00 per share.
    • HWH International Inc. (NASDAQ:HWH) shares fell 16.3% to $2.36 in pre-market trading after dipping 26% on Tuesday.
    • NexImmune, Inc. (NASDAQ:NEXI) shares fell 12.6% to $10.31 in pre-market trading after jumping over 55% on Tuesday.
    • MicroCloud Hologram Inc. (NASDAQ:HOLO) fell 10.2% to $0.2672 in pre-market trading after gaining 22% on Tuesday.
    • Elevation Oncology, Inc. (NASDAQ:ELEV) shares fell 8.1% to $1.81 in pre-market trading after gaining around 9% on Tuesday. Elevation Oncology recently said that it plans to provide an update from its ongoing Phase 1 trial of EO-3021 in mid-2024, with additional data expected in the first half of 2025.
    • Galera Therapeutics, Inc. (NASDAQ:GRTX) shares fell 7.4% to $0.1952 in pre-market trading after jumping 41% on Tuesday.
    • Wearable Devices Ltd. (NASDAQ:WLDS) fell 6.7% to $0.42 in pre-market trading.
    • AERWINS Technologies Inc. (NASDAQ:AWIN) shares declined 6.5% to $0.1230 in pre-market trading. AERWINS Technologies recently entered into a letter of intent to form an entity with Helicopter Technology.
    • Sasol Limited (NYSE:SSL) shares fell 4.7% to $9.28 in pre-market trading.

     

    Now Read This: Citigroup Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

    Get the next $AEHR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEHR
    $AWIN
    $ELEV
    $GGE

    CompanyDatePrice TargetRatingAnalyst
    Sasol Ltd.
    $SSL
    2/9/2026Buy → Neutral
    Goldman
    Intuitive Surgical Inc.
    $ISRG
    1/27/2026$660.00Buy
    TD Cowen
    Sasol Ltd.
    $SSL
    1/16/2026Neutral → Underweight
    Analyst
    Aehr Test Systems
    $AEHR
    12/17/2025$29.00Buy
    Lake Street
    Intuitive Surgical Inc.
    $ISRG
    12/11/2025$635.00Buy → Neutral
    Citigroup
    TG Therapeutics Inc.
    $TGTX
    10/6/2025$60.00Buy
    H.C. Wainwright
    Sasol Ltd.
    $SSL
    9/22/2025Overweight → Equal-Weight
    Morgan Stanley
    Intuitive Surgical Inc.
    $ISRG
    7/23/2025Buy → Hold
    Erste Group
    More analyst ratings

    $AEHR
    $AWIN
    $ELEV
    $GGE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for BRIUMVI issued to TG THERAPEUTICS, INC

    Submission status for TG THERAPEUTICS, INC's drug BRIUMVI (SUPPL-11) with active ingredient UBLITUXIMAB-XIIY has changed to 'Approval' on 10/30/2024. Application Category: BLA, Application Number: 761238, Application Classification:

    10/31/24 4:38:40 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for BRIUMVI issued to TG THERAPEUTICS, INC

    Submission status for TG THERAPEUTICS, INC's drug BRIUMVI (ORIG-1) with active ingredient UBLITUXIMAB has changed to 'Approval' on 12/28/2022. Application Category: BLA, Application Number: 761238, Application Classification:

    12/28/22 12:54:09 PM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for UKONIQ

    Submission status for TG THERAPEUTICS INC's drug UKONIQ (ORIG-1) with active ingredient UMBRALISIB TOSYLATE has changed to 'Approval' on 02/05/2021. Application Category: NDA, Application Number: 213176, Application Classification: Type 1 - New Molecular Entity

    2/9/21 12:05:59 PM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEHR
    $AWIN
    $ELEV
    $GGE
    SEC Filings

    View All

    TG Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - TG THERAPEUTICS, INC. (0001001316) (Filer)

    2/26/26 7:08:34 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form F-1 filed by Wearable Devices Ltd.

    F-1 - Wearable Devices Ltd. (0001887673) (Filer)

    2/23/26 4:02:28 PM ET
    $WLDS
    Computer Communications Equipment
    Telecommunications

    SEC Form 6-K filed by Sasol Ltd.

    6-K - SASOL LTD (0000314590) (Filer)

    2/23/26 11:55:35 AM ET
    $SSL
    Oil & Gas Production
    Energy

    $AEHR
    $AWIN
    $ELEV
    $GGE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Schonfeld Strategic Advisors Llc sold $79,589 worth of shares (41,400 units at $1.92) and bought $372,143 worth of shares (146,800 units at $2.54) (SEC Form 4)

    4 - iCoreConnect Inc. (0001906133) (Issuer)

    4/28/25 6:12:27 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology

    Large owner Hitron Systems Inc. bought $8,700,000 worth of shares (2,900,000 units at $3.00), increasing direct ownership by 669% to 3,333,333 units (SEC Form 4)

    4 - EXICURE, INC. (0001698530) (Issuer)

    3/26/25 5:41:19 PM ET
    $XCUR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Chang Nancy T bought $499,979 worth of shares (7,644,932 units at $0.07) (SEC Form 4)

    4 - Galera Therapeutics, Inc. (0001563577) (Issuer)

    1/2/25 4:12:36 PM ET
    $GRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEHR
    $AWIN
    $ELEV
    $GGE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    MicroCloud Hologram Inc. Proposes Quantum AI Simulator Adopting Hybrid CPU-FPGA Method, Achieving Efficient Image Classification Simulation Through Heterogeneous Computing

    SHENZHEN, China, Feb. 26, 2026 (GLOBE NEWSWIRE) -- MicroCloud Hologram Inc. (NASDAQ:HOLO), ("HOLO" or the "Company"), a technology service provider, proposed a quantum AI simulator that adopts a hybrid CPU-FPGA method. This system performs hardware-level optimization on the specific structure of quantum kernels through a heterogeneous computing architecture, making quantum kernel estimation 500 times faster than traditional CPU simulation implementations under the same computational scale, providing unprecedented acceleration capabilities for the application simulation of quantum artificial intelligence. This technology of HOLO focuses on application-specific quantum kernels (ASQK) design

    2/26/26 8:00:00 AM ET
    $HOLO
    Computer Software: Programming Data Processing
    Technology

    TG Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Raises BRIUMVI Revenue Guidance

    Fourth quarter and full year 2025 total revenue of $192.6 million and $616.3 million, including BRIUMVI U.S. net revenue of $182.7 million and $594.1 million, respectively Target guidance of approximately $875-900 million in total global revenue for 2026 Conference call to be held today, Thursday, February 26, 2026, at 8:30 AM ET NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX) (the Company or TG Therapeutics) today announced its financial results for the fourth quarter and full year ended December 31, 2025, along with recent company developments and 2026 financial guidance. Michael S. Weiss, the Company's Chairman and Chief Executive Off

    2/26/26 7:00:00 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    MicroCloud Hologram Inc. FPGA-Based High-Performance Surface Code Quantum Simulation Platform: Efficient Error Correction Algorithm Validation under Rotated Layout

    SHENZHEN, China, Feb. 25, 2026 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ:HOLO), ("HOLO" or the "Company"), a technology service provider, has developed a surface code quantum simulator based on FPGA. This innovative technology marks a new milestone in quantum error correction simulation, particularly with its optimized design targeted at rotated surface codes. As a company focused on quantum hardware and simulation solutions, the simulator launched this time fully leverages the unique advantages of FPGA (Field-Programmable Gate Array), including its highly parallel processing capability, reconfigurable hardware architecture, and exceptional computational performance. Quantum error cor

    2/25/26 10:50:00 AM ET
    $HOLO
    Computer Software: Programming Data Processing
    Technology

    $AEHR
    $AWIN
    $ELEV
    $GGE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $AEHR
    $AWIN
    $ELEV
    $GGE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Sasol downgraded by Goldman

    Goldman downgraded Sasol from Buy to Neutral

    2/9/26 7:00:29 AM ET
    $SSL
    Oil & Gas Production
    Energy

    TD Cowen initiated coverage on Intuitive Surgical with a new price target

    TD Cowen initiated coverage of Intuitive Surgical with a rating of Buy and set a new price target of $660.00

    1/27/26 8:46:58 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    Sasol downgraded by Analyst

    Analyst downgraded Sasol from Neutral to Underweight

    1/16/26 8:32:37 AM ET
    $SSL
    Oil & Gas Production
    Energy

    Director Ying Wei was granted 67,857 shares, increasing direct ownership by 23% to 368,789 units (SEC Form 4)

    4 - Microvast Holdings, Inc. (0001760689) (Issuer)

    2/25/26 6:55:11 PM ET
    $MVST
    Industrial Machinery/Components
    Miscellaneous

    Chief Accounting Officer Miller Josh covered exercise/tax liability with 8 shares, decreasing direct ownership by 3% to 301 units (SEC Form 4)

    4 - EXICURE, INC. (0001698530) (Issuer)

    2/19/26 2:27:21 PM ET
    $XCUR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP - CLO, CRCO Velasco Francisco sold $52,292 worth of shares (338 units at $154.71), decreasing direct ownership by 0.44% to 75,997 units (SEC Form 4)

    4 - PRICESMART INC (0001041803) (Issuer)

    2/18/26 3:58:12 PM ET
    $PSMT
    Department/Specialty Retail Stores
    Consumer Discretionary

    $AEHR
    $AWIN
    $ELEV
    $GGE
    Leadership Updates

    Live Leadership Updates

    View All

    CHANGES TO SASOL LIMITED BOARD OF DIRECTORS

    JOHANNESBURG, Jan. 21, 2026 /PRNewswire/ -- In compliance with para 3.59 of the JSE Listings Requirements and para 6.39 of the JSE Debt and Specialist Securities Listings Requirements, Sasol is pleased to announce the appointment of Mr Rhidwaan Gasant as independent non-executive director with effect from 1 February 2026. Mr Gasant satisfies the independence requirements for directors under applicable requirements in South Africa and the United States. Mr Gasant is a Chartered Accountant and served as a senior audit manager at KPMG before joining Mobil Oil Southern Africa. He was the former Financial Director of Engen Limited and Chief Executive Officer of Energy Africa Limited. Mr Gasant h

    1/21/26 10:01:00 AM ET
    $SSL
    Oil & Gas Production
    Energy

    Intel Appoints Dr. Craig H. Barratt to Board of Directors

    Intel Corporation (NASDAQ:INTC) today announced that Craig H. Barratt, Ph.D., 63, has been appointed to its board of directors, effective immediately. Dr. Barratt will serve as an independent director. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251110908011/en/Dr. Craig H. Barratt joins Intel's board as an independent director. "Craig is a highly accomplished technology leader with a proven ability to innovate, scale, and transform businesses," said Lip-Bu Tan, Intel CEO. "He is a seasoned semiconductor executive with experience at multiple leading-edge technology companies, which will be invaluable as we continue to execute

    11/10/25 6:21:00 PM ET
    $ALAB
    $INTC
    $ISRG
    Semiconductors
    Technology
    Industrial Specialties
    Health Care

    Wearable Devices Expands into Asia's Tech Powerhouse: Secures Exclusive Distribution Agreement in South Korea

    Mudra Band and Mudra Link neural wristbands enter South Korea - a global hub for wearable innovation and home to leading electronics companies such as Samsung Group and LG Electronics Inc. Yokneam Illit, Israel, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (NASDAQ:WLDS, WLDSW)) (the "Company" or "Wearable Devices"), a technology growth company specializing in artificial intelligence ("AI")-powered touchless sensing wearables, recently announced that it has entered into an exclusive distribution agreement (the "Agreement") with Sky Commerce Co., Ltd. ("Sky Commerce"), securing a strategic foothold in South Korea - a global hub for wearable innovation and home to leading consume

    11/7/25 9:00:00 AM ET
    $WLDS
    Computer Communications Equipment
    Telecommunications

    $AEHR
    $AWIN
    $ELEV
    $GGE
    Financials

    Live finance-specific insights

    View All

    TG Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Raises BRIUMVI Revenue Guidance

    Fourth quarter and full year 2025 total revenue of $192.6 million and $616.3 million, including BRIUMVI U.S. net revenue of $182.7 million and $594.1 million, respectively Target guidance of approximately $875-900 million in total global revenue for 2026 Conference call to be held today, Thursday, February 26, 2026, at 8:30 AM ET NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX) (the Company or TG Therapeutics) today announced its financial results for the fourth quarter and full year ended December 31, 2025, along with recent company developments and 2026 financial guidance. Michael S. Weiss, the Company's Chairman and Chief Executive Off

    2/26/26 7:00:00 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2025 Financial Results and Business Update

    NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), today announced that a conference call will be held, Thursday, February 26, 2026, at 8:30 AM ET to discuss results for the fourth quarter and full year 2025 and to provide a business outlook for 2026. Michael S. Weiss, Chairman and Chief Executive Officer, will host the call. In order to participate in the conference call, please call 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the U.S.), Conference Title: TG Therapeutics Earnings Call. A live webcast of this presentation will be available on the Events page, located within the Investors & Media section, of the Company's website at www.tgtherapeutics.com.

    2/23/26 7:30:00 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SHORT FORM ANNOUNCEMENT: REVIEWED FINANCIAL RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2025 AND UPDATED BUSINESS OUTLOOK

    JOHANNESBURG, Feb. 23, 2026 /PRNewswire/ -- Sasol has released its operating and financial results for the six months ended 31 December 2025 (H1 FY26). Highlights:Turnover of R122,4 billion remained flat compared to prior period, supported by 3% increase in sales volumes and despite the softer macro environmentSecunda Operations' (SO) production volumes 10% higherLower cash fixed cost compared to the prior period, reflecting disciplined cost managementAdjusted EBITDA of R21,0 billion, 12% lower than the prior periodEarnings before interest and tax (EBIT) of R4,6 billion, 52% lower than the prior periodHeadline earnings per share (HEPS) of R9,27 per share, 34% lower than the prior periodCapit

    2/23/26 1:09:00 AM ET
    $SSL
    Oil & Gas Production
    Energy

    $AEHR
    $AWIN
    $ELEV
    $GGE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by iCoreConnect Inc.

    SC 13G/A - iCoreConnect Inc. (0001906133) (Subject)

    12/12/24 9:44:00 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by iCoreConnect Inc.

    SC 13G/A - iCoreConnect Inc. (0001906133) (Subject)

    12/5/24 4:08:58 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13D filed by Exicure Inc.

    SC 13D - EXICURE, INC. (0001698530) (Subject)

    11/29/24 5:51:28 PM ET
    $XCUR
    Biotechnology: Pharmaceutical Preparations
    Health Care